A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing

Human Immunology

Volumn 72, Issue 9, 2011, Pages 717-722

  Dunn, Paul P J ^a   Hammond, Laura ^a   Coates, Ernest ^b   Street, Jane ^b   Griner, Leon ^a   Darke, Christopher ^b  

^a New Zealand Blood Service   (New Zealand)

^b Welsh Blood Service   (United Kingdom)

Author keywords

Alternative splicing; HLA A*01:01:38L; Low expression allele; Silent substitution

Indexed keywords

ALLOANTIBODY; COMPLEMENTARY DNA; GENOMIC DNA; HLA A ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ALLELE; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CELL SURFACE; CODON; DNA MODIFICATION; DNA SEQUENCE; DNA SYNTHESIS; EPSTEIN BARR VIRUS; EXON; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; NUCLEOTIDE SUBSTITUTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROCESSING; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BLOOD GROUPING AND CROSSMATCHING; BONE MARROW TRANSPLANTATION; CELL LINE, TRANSFORMED; CELL SEPARATION; EXONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY TESTING; HLA-A1 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; NUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION;

EID: 84860388839     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.019     Document Type: Article

References (31)

1. Meyer D., Single R.M., Mack S.J., Lancaster A., Nelson M.P., Erlich H.A., et al. Single locus polymorphism of classical HLA genes. Immunobiology of the Human MHC Proceedings of the 13th International Histocompatibility Workshop and Conference, vol 1 2006, 653-704. International Histocompatibility Working Group, Fred Hutchinson Cancer Research Center, Seattle. J.A. Hansen (Ed.).
2. Lardy N.M., Bakas R.M., van der Horst A.R., van Twuyver E., Bontrop R.E., de Waal L.P. Cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals. J Immunol 1992, 148:2572-2577.
3. Parham P. Filling in the blanks. Tissue Antigens 1997, 50:318-321.
4. Dormoy A., Hanau D., Cazenave J.-P., Tongio M.-M. 13th IHWS HLA Null Alleles Joint Report. H1. Non expressed HLA alleles. Immunobiology of the Human MHC Proceedings of the 13th International Histocompatibility Workshop and Conference, vol 1 2006, 1143-1163. International Histocompatibility Working Group Press, Fred Hutchinson Cancer Research Center, Seattle. J.A. Hansen (Ed.).
5. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for Factors of the HLA System, 2010. Tissue Antigens 2010, 75:291-455.
6. Holdsworth R., Hurley C.K., Marsh S.G., Lau M., Noreen H.J., Kempenich J.H., et al. The HLA Dictionary 2008: a summary of HLA-A,-B,-C,-DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A,-B,-C,-DR, and -DQ antigens. Tissue Antigens 2009, 73:95-170.
7. Hammond L., Street J., Downing J., Pepperall J., Darke C. Distribution of HLA-A and -B expression variants in 16,739 "Welsh" subjects. Int J Immunogenet 2007, 34:304.
8. Elsner H.-A., Blasczyk R. Immunogenetics of HLA null alleles: implications for blood stem cell transplantation. Tissue Antigens 2004, 64:687-695.
9. Smith D.M., Baker J.E., Gardner W.B., Martens G.W., Agura E.D. HLA class I null alleles and new alleles affect unrelated bone marrow donor searches. Tissue Antigens 2005, 66:93-98.
10. Reinders J., Rozemuller E.H., Otten H.G., Houben A.J.S., Dormoy A., Mulder A., et al. Identification of HLA-A*0111N: a synonymous substitution, introducing an alternative splice site in exon 3, silenced the expression of an HLA-A allele. Hum Immunol 2005, 66:912-920.
11. Elsner H.-A., Bernard G., Eiz-Vesper B., de Matteis M., Bernard A., Blasczyk R. Non-expression of HLA-A*2901102N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron 4. Tissue Antigens 2002, 59:139-141.
12. Curran M.D., Williams F., Little A.-M., Rima B.K., Madrigal J.A., Middleton D. Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 1999, 53:244-252.
13. Laforet M., Froelich A., Parissiadis A., Bausinger H., Pfeiffer B., Tongio M.M. An intronic mutation responsible for a low level of expression of an HLA-A*24 allele. Tissue Antigens 1997, 50:340-346.
14. Marsh S.G. Nomenclature for Factors of the HLA System, Update January 2009. Tissues Antigens 2009, 74:177-179.
15. Marsh S.G. Nomenclature for Factors of the HLA System, Update March 2011. Tissue Antigens 2011, 78:77-79.
16. Darke C. An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision. Bone Marrow Transplant 2000, 25:771-777.
17. Downing J., Guttridge M.G., Thompson J., Darke C. Five-locus HLA typing of hematopoietic stem cell donor volunteers using PCR sequence specific primers. Genet Test 2004, 8:301-312.
18. Dunn P.P.J., Day S., Williams S., Bendukidze N. HLA sequencing as a tissue typing tool. Pediatric Hematology 2003, 233-246. Humana Press, Totowa, NJ. N. Goulding, C. Seward (Eds.).
19. Bunce M., O'Neill C.M., Barnardo M.C., Krausa P., Browning M.J., Morris P.J., et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
20. Bass H., Walters R., Darke C. Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications. Eur J Immunogenet 2004, 31:87-92.
21. Darke C., Dyer P.A. Clinical HLA typing by cytotoxicity. Histocompatibility Testing: A Practical Approach 1993, 51-80. IRL Press, New York: Oxford. P.A. Dyer, D. Middleton (Eds.).
22. Guttridge M.G., Thompson J., Street J., Darke C. Identification, sequencing and serology of HLA-B*3527. Tissue Antigens 1999, 53:383-385.
23. Eden E., Brunak S. Analysis and recognition of 5' UTR intron splice sites in human pre-mRNA. Nucleic Acids Res 2004, 32:1131-1142.
24. Desmet F.-O., Hamroun D., Lalande M., Collod-Beroud G., Claustres M., Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009, 37:1131-1142.
25. Kostyu D.D., Hannick L.I., Traweek J.L., Ghanayem M., Heilpern D., Dawson D. HLA class I polymorphism: structure and function and still questions. Hum Immunol 1997, 57:1-18.
26. Lee K.W., Shin J.-Y., Lee J.-Y. Expression defect of an HLA-A*24 allele associated with DNA methylation in a normal individual. Tissue Antigens 2003, 61:325-329.
27. Marsh S.G. Nomenclature for factors of the HLA system, update April 2007. Tissue Antigens 2007, 70:174-176.
28. Yan L.X., Zhu F.M., He J., Zhang W. Five novel HLA-A alleles, HLA-A*030108, A*2491, A*2498, A*330303, A*3317 were identified by polymerase chain reaction sequence based typing. Tissue Antigens 2009, 74:432-434.
29. Sutton V.R., Kienzle B.K., Knowles R.W. An altered splice site is found in the DRB4 gene that is not expressed in HLA-DR7, Dw11 individuals. Immunogenetics 1990, 29:317-322.
30. Tijssen H.J., Sistermans E.A., Joosten I. A unique second donor splice site in the intron 5 sequence of the HLA-A*11 alleles results in a class I transcript encoding a molecule with an elongated cytoplasmic domain. Tissue Antigens 2000, 55:422-428.
31. Johnson J.M., Castle J., Garrett-Engele P., Kan Z., Loerch P.M., et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302:2141-2144.